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Abstract
Influence of menstrual cycle phase on experimental pain sensitivity in women and on gender
differences in pain sensitivity was examined in 48 men and 49 women in response to cold pressor,
heat, and ischemic pain. Each woman was tested at three points in their menstrual cycle in randomized
order, the early follicular, late follicular, and luteal phases, while men were also tested three times,
controlling for number of days between test sessions. Cycle phase was confirmed via serum hormone
levels. As expected, women were significantly more sensitive to cold pain (p < .01), to heat pain
(p < .0001), and to ischemic pain (p < .01) than men. However, pain perception during each task was
not influenced by the menstrual cycle in women, nor did the menstrual cycle influence the magnitude
of the gender differences in pain sensitivity. These results indicate that although women are more
sensitive to a variety of noxious stimuli than men, menstrual cycle phase does not appear to moderate
those differences in healthy men and women.
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1. Introduction
It is well established that men and women differ in their perception and experience of pain. In
the general population, women report more pain, experience increased severity, frequency, and
duration of pain (Unruh, 1996), and are more likely to develop headaches, rheumatoid arthritis,
temporomandibular disorders, fibromyalgia, and irritable bowel syndrome than men (Unruh,
1996; Berkley, 1997; Fillingim, 2000). Potential explanations for gender differences in clinical
pain can be derived from investigations exploring gender differences in experimental pain
perception. A robust finding in the literature is that women display greater pain sensitivity to
noxious stimuli than men (Fillingim and Maixner, 1995; Berkley, 1997; Riley et al., 1998;
Fillingim, 2000; Shinal and Fillingim, 2007), although the magnitude varies from large to
moderate depending on sample size, nature of the stimulus, and whether pain sensitivity is
indexed by threshold or tolerance (Riley et al., 1998; Shinal and Fillingim, 2007).
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The higher prevalence for clinical pain and greater experimental pain sensitivity in women
suggest a role for female sex hormones (Fillingim and Ness, 2000; Aloisi, 2003). Analgesic
effects of estrogen and progesterone in animals have been documented (Fillingim and Ness,
2000), but consistency in the pattern and direction of the relationship between hormones and
nociception is lacking and underlying mechanisms have yet to be elucidated (Sherman and
LeResche, 2006). In animals, cyclic variation of ovarian hormones has been shown to affect
sensitivity to pain stimuli as well as morphine nociception (Ryan and Maier, 1988; Frye et al.,
1992; Martinez-Gomez et al., 1994; Kayser et al., 1996; Sapsed-Byrne et al., 1996; Mogil et
al., 2000; Vincler et al., 2001; Vinogradova et al., 2003; Shekunova and Bespalov, 2004; Terner
et al., 2005). However, inconsistencies exist regarding which estrous phases are associated
with greater nociception (Fillingim and Ness, 2000; Sherman and LeResche, 2006; Craft,
2007).
Methodological issues may also contribute to inconsistent findings on menstrual cycle and pain
sensitivity in humans. Despite the consensus of previous literature reviews (Goolkasian,
1980; Riley et al., 1999; Fillingim and Ness, 2000) that menstrual cycle influences pain
perception in women, with greatest sensitivity occurring in the ovulatory or luteal phase, a
recent review came to a contradictory conclusion. After reviewing 14 studies investigating
menstrual cycle effect on pain sensitivity, Sherman and LeResche (2006) concluded that there
was no consistent evidence for a menstrual cycle effect on pain perception to a variety of
noxious stimuli, with the possible exception of higher pain thresholds to electric pain in the
post-ovulatory phase. This review focused on pervasive methodological issues that have
limited conclusions from existing studies such as lack of biological markers confirming cycle
phase, use of between-subjects designs, small sample sizes, lack of a standardized definition
and nomenclature for each cycle phase, and lack of standardized delivery of stimuli (Sherman
and LeResche, 2006). Despite inconsistencies regarding phase effects in women, an
unanswered question is whether menstrual cycle influences gender differences in pain
perception. Consequently, the present study addressed the abovementioned methodological
issues in order to examine the influence of cycle phase on gender differences in pain sensitivity.
2. Methods
2.1. Subjects
Subjects were recruited through newspaper advertisements seeking male and female
nonsmokers for a study on pain perception. Of those who responded, 97 met all inclusion/
exclusion criteria and constitute the subjects in this report. The subjects were composed of 48
men and 49 women, aged 18–47 years. Male and female subjects reflected an ethnically diverse
sample (49% African American, 39% Caucasian, 5% Indian, 5% Asian, and 2% Hispanic). All
subjects were medically healthy, with no more than mildly elevated blood pressure (BP)
(<160/90 mm Hg) as determined during an initial screening session. Additionally, subjects
were not taking any prescription medication, including oral contraceptives, and not taking any
over-the-counter medication on a regular basis (e.g. nonsteroidal anti-inflammatory agents,
antihistamines). All women reported regular menstrual cycles (24–32 days). Excluded from
participation were subjects with chronic pain conditions (e.g. temporomandibular joint
disorder, fibromyalgia, arthritis) and those exhibiting signs of depression or anxiety.
Individuals with Hamilton scale (Williams, 1988) depression ratings greater than seven
(indicating mild depression) or anxiety ratings greater than nine (indicating symptoms of
anxiety) were excluded. The protocol was approved by the institution’s Institutional Review
Board, and all subjects provided informed, written consent before participating. Subjects
received $500 compensation.
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In order to minimize any influence that novelty of exposure to the laboratory and pain-testing
apparatuses would have on pain perception, during an initial screening session subjects were
shown the laboratory and the pain-testing equipment, had the procedures described to them,
and then underwent a preliminary heat pain threshold assessment.
For all subjects, laboratory testing began between 12 PM and 2 PM. Each woman was tested
at three points in her menstrual cycle, early follicular (EF) (days 2–5), late follicular (LF) (days
7–12), and luteal (LUT) (8–12 days after home urine testing revealed the LH surge that precedes
ovulation by 24–36 h). Order of phase was randomized across female subjects. When no LH
surge was detected (indicating anovulation), women were tested in the subsequent luteal phase
contingent on the LH surge. Menstrual cycle phase was subsequently confirmed using serum
estradiol and progesterone concentrations. Men were also tested three times, matching each
consecutive man and woman for number of days between test sessions.
Another goal of the research project was to examine stress-induced analgesia (SIA) (Mechlin
et al., 2005). Thus, for each subject and in each cycle phase, pain testing occurred twice, once
following the Trier Social Stress Test (TSST) (Kirschbaum et al., 1993) and once following a
time equivalent Rest Control period. The order of Stress versus Rest was fully counterbalanced
by gender, and for each subject order was held constant over the three test sessions. Although
we have previously reported that little evidence of SIA was present in either gender (Mechlin
et al., 2005), in order to minimize any potential influence of the mental stressor battery on pain
sensitivity, only the results of the pain testing that followed the Rest Control period (see below)
are included in this report. It may be important to note that for those subjects who received the
Stress Condition first, (50% of the men and 50% of the women) a minimum of 1 h elapsed
between the completion of the stress testing and the pain testing that followed the Rest
Condition. Thus, given that little evidence for SIA was seen when pain testing immediately
followed the mental stress (Mechlin et al., 2005), with at least 60 min elapsing prior to pain
testing, it is exceedingly unlikely that stress responses would carry over to influence pain
responses following the Rest Condition.
2.2.1. Rest Control period—Immediately prior to pain-testing, subjects rested quietly alone
in a comfortable seated position for 20 min.
2.2.2. Pain-testing procedures—Immediately after the Rest Control period, subjects were
exposed to the three different pain tests. One of three task orders (i.e. (A) tourniquet, heat, cold;
(B) heat, cold, tourniquet; or (C) cold, tourniquet, heat) was randomly assigned to each subject,
ensuring that equal numbers of men and women received each of the three orders. This task
order remained the same on each of the three testing sessions, and there was a 5 min recovery
period following each pain test. Pain intensity and unpleasantness ratings were obtained for
each of the three pain tasks. Subjects were instructed that at the point of tolerance for each pain
test, they would be asked to rate the intensity and unpleasantness of their pain using separate
visual analog scales (0–100). Thus, immediately before deflating the tourniquet cuff,
immediately before removal of the hand from the ice bath, and immediately after the third heat
tolerance temperature was delivered, the experimenter held up a visual analog scale for
intensity rating, with the 100-cm line anchored by the words “not at all intense” and “the most
intense pain imaginable.” Next, the experimenter held up a scale for unpleasantness, with the
100-cm line anchored by the words “not at all unpleasant” and ‘‘the most unpleasant pain
imaginable.”
2.2.2.1. The submaximal effort tourniquet procedure: In this procedure, as described
previously (Maixner et al., 1990), a tourniquet cuff was positioned on the subject’s arm and
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the arm placed to the side. Before inflating the tourniquet cuff to 200 mmHg (Hokanson E20
Rapid Cuff Inflator), the subject’s arm was raised for 30 s to promote venous drainage, and
then the cuff was inflated, the experimenter’s stopwatch started, and the arm returned to the
side. To promote forearm ischemia, subjects engaged in 20 handgrip exercises at 30% of their
maximum force with an intersqueeze interval of 2 s. Subjects were instructed to indicate when
the sensations in their arm first became painful (pain threshold) and when they were no longer
willing or able to tolerate the pain (pain tolerance). A maximum time limit of 20 min was
enforced, though subjects were not informed of this limit.
2.2.2.2. Hand cold pressor: The apparatus for the cold pressor consisted of a container filled
with ice and water that was maintained at 4 °C as recorded immediately before initiating the
test. The use of a water circulator prevented the water from warming near the subject’s hand.
At the onset of the test, subjects were instructed to submerge their hand to the marked line on
their wrist and to remain still. Subjects were instructed to indicate to the experimenter when
the sensations in their hand first became painful (pain threshold) and to also indicate when they
were no longer willing or able to tolerate the pain by saying “stop” (pain tolerance). A maximum
time limit of 5 min was imposed, though subjects were not informed of this limit.
2.2.2.3. Heat pain testing: Heat pain threshold and tolerance were determined by an ascending
method of limits using a 1-cm-diameter contact thermode with the capability for a rise time of
10 °C/s. The thermode was controlled by a personal computer, and heat probe applied to the
left volar forearm. During the pain testing, an adapting temperature of 38 °C was maintained
for 10 s. Then, the temperature increased directly to 41.5 °C and from that point on increased
0.5 °C every 5 s until it reached 53 °C or until the subject reached his/her tolerance. To
determine heat pain onset (threshold), subjects were instructed to press a mouse button (which
terminated the stimulus) when the heat percept first became painful. This was repeated three
times and averaged to calculate heat pain thresholds. Then, three series to determine average
heat pain tolerance were conducted by instructing the subject to press a mouse button when
they were no longer willing or able to tolerate the pain.
2.3. Data reduction and analyses
We first assessed for gender differences in the demographic variables of age and body mass
index (BMI) using a one-way analysis of variance (ANOVA) for each variable. We then
examined serum estradiol and serum progesterone levels in women across menstrual cycle
phase, using a repeated-measure ANOVA, with menstrual cycle phase as the repeated factor.
Contrast analyses were performed where significant main effects arose.
Next, we examined menstrual cycle effects in pain threshold and tolerance separately for each
of the three pain tasks, using a 2 (Gender) × 2 (Time Point: Threshold/Tolerance) × 3 (Menstrual
Cycle Phase) repeated-measures ANOVA, with time point and menstrual cycle phase as
repeated factors. Where significant interactions emerged, subsequent simple effects analyses
were conducted in order to explore those effects.
We then determined gender and menstrual cycle phase differences in intensity and
unpleasantness ratings for each pain task by using a 2 (Gender) × 3 (Menstrual Cycle Phase)
repeated-measures ANOVA, with menstrual cycle phase as the repeated factor.1 Based on
Cohen’s measure of effect size (Cohen, 1992), with a sample size of 49 women we had greater
than 90% power to detect a moderate effect size (Cohen’s d = 0.50), defined as the difference
between pain tolerance levels between each menstrual cycle phase.
1Finally, in order to assess any spurious differences in pain sensitivity across the 3 testing sessions in males, we examined “cycle phase”
differences in men using a repeated measures ANOVA. As expected, no cycle effect was present for males (Fs = 0.29−1.31, ps = 0.28
−0.75)
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Finally, with the aim of examining whether any consistent effects of task order on pain
threshold and tolerance were present, a 3 (Order: A-tourniquet, heat, cold; B-heat, cold,
tourniquet; or C-cold, tourniquet, heat) × 3 (Menstrual Cycle Phase) repeated-measures
ANOVA, with menstrual cycle phase as the repeated factor, was performed separately for each
time point (threshold and tolerance) and for each of the pain tasks. No robust effect of task
order on any measure of pain threshold or tolerance was found (all ps > .16), with the only
significant effect being a main effect of order for cold pressor tolerance (F(2,94) = 4.3, p < .
05), since greater cold pressor tolerance during task order A compared to task order B existed,
a difference that was not affected by menstrual cycle phase.
3. Results
There were no gender differences in the demographic factors of age or BMI. Females were on
average 28 (±0.85) years of age compared to 27.3 (±0.86) years of age in males, while the mean
BMI for females was 27 (±0.92), versus 27.4 (±0.93) in males. As summarized in Table 1,
main effects of menstrual cycle phase were found for both estradiol (F(2,96) = 38.73, p < .
0001) and progesterone (F(2,96) = 143.8, p < .0001). As expected, contrast analyses for
estradiol levels revealed that EF levels were significantly lower than LF levels (F(1,48) = 37.15,
p < .0001), which were significantly lower than LUT levels (F(1,48) = 6.1, p < .05). Also as
expected, LUT progesterone levels were significantly greater than both EF (F(1,48) = 144.29,
p < .0001) and LF levels (F(1,48) = 143.49, p < .0001), but EF and LF progesterone levels
were not significantly different from each other. These results confirm that women were tested
at the appropriate points in their menstrual cycle.
Women were significantly more sensitive to cold pain (lower threshold and tolerance) (F(1,95)
= 9.57, p < .01), to heat pain (F(1,92) = 24.56, p < .0001), and to ischemic pain (F(1,87) = 9.0,
p < .01) than men (Fig. 1, Fig. 2, Fig 3).
Although the anticipated gender differences were present for all three pain tasks, no significant
interactions were present involving gender and menstrual cycle phase. Thus, there was no
evidence that the female menstrual cycle influenced pain threshold or tolerance in women, nor
was there evidence that it influenced the magnitude of the gender differences2.
Pain intensity and unpleasantness ratings for all three pain tasks are reported in Table 2.
Females had greater cold pain intensity (F(1,95) = 13.76, p < .001) and unpleasantness (F
(1,95) = 12.5, p < .001) ratings than males. No interactions involving gender or menstrual cycle
phase were present for cold pain intensity or unpleasantness, therefore gender differences in
cold pain intensity and unpleasantness ratings did not vary by menstrual cycle phase. Finally,
no main effects or interactions were revealed for heat or ischemic pain intensity or
unpleasantness ratings. Thus, despite women showing lower pain thresholds and tolerance
values, the genders did not differ in verbal ratings of pain intensity and unpleasantness for
either the heat or ischemic pain tests.
3.1. Secondary analyses examining race×phase effects on pain sensitivity
In a post-hoc fashion, in order to explore whether the racial diversity of our sample contributed
to the absence of a menstrual cycle effect on pain sensitivity in women, we examined menstrual
cycle effects in pain threshold and tolerance separately for each of the three pain tasks using a
2 (Race) × 2 (Time Point) × 2 (Menstrual Cycle Phase) repeated-measures ANOVA with time
point and menstrual cycle phase as repeated factors, comparing the two primary racial groups,
African Americans (N = 25), and Non-Hispanic Whites (N = 19). Results revealed no
2The influence of the menstrual cycle on pain threshold and tolerance was not moderated by race (African American vs. non-Hispanic
White; Fs = 0.32–1.69, ps = 0.19–0.72)
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significant Race × Phase effects (all ps > .54), indicating that our racial diversity of the sample
did not contribute to the lack of menstrual cycle influence on pain perception reported.
3.2. Correlations involving sex hormone levels and pain sensitivity in women
Consistent with the absence of a menstrual cycle effect on pain sensitivity, in women, there
was no evidence of meaningful correlations involving estradiol or progesterone levels and pain
threshold or tolerance in any cycle phase for any pain task (all rs = −.27 − .14; all ps > .05).
The only exception was in the early follicular phase involving heat pain threshold and
progesterone (r = −.34, p < .05). The lack of a consistent pattern suggests that this effect is
likely to be spurious.
4. Discussion
The results of our study confirm previous findings that women are more sensitive to a variety
of laboratory-based noxious stimuli than men (Fillingim and Maixner, 1995; Berkley, 1997;
Riley et al., 1998; Fillingim, 2000), while also suggesting that menstrual cycle phase does not
influence pain sensitivity in women, nor does it have an effect on the magnitude of gender
differences in pain perception. Initially, the lack of a menstrual cycle effect on pain sensitivity
in women may seem contrary to expectations based on previous animal (Ryan and Maier,
1988; Frye et al., 1992; Martinez- Gomez et al., 1994; Kayser et al., 1996; Sapsed-Byrne et
al., 1996; Mogil et al., 2000; Vincler et al., 2001; Vinogradova et al., 2003; Shekunova and
Bespalov, 2004; Terner et al., 2005) and human research (Goolkasian, 1980; Riley et al.,
1999; Fillingim and Ness, 2000). However, recent reviews assessing the association between
the estrous cycle and nociception in non-humans show inconclusive results (Fillingim and
Ness, 2000; Craft, 2007). Although studies in non-humans generally support an effect of go-
nadal hormones on sensitivity to noxious stimuli (Goolkasian, 1980; Riley et al., 1999;
Fillingim and Ness, 2000), there is no consistent evidence in the pattern and direction of this
relationship (Fillingim and Ness, 2000) or a consensus as to which estrous cycle phase is
associated with the greatest nociception (Craft, 2007), if any (Ryan and Maier, 1988).
Additionally, our results are supported by a recent study by Kowalczyk et al. (2006) showing
no effect of menstrual cycle phase on cold pressor pain threshold and tolerance in normally
menstruating women, and by a methodological review concluding that there is no consistent
evidence for an effect of the menstrual cycle on the vast majority of laboratory-based noxious
stimuli in humans (Sherman and LeResche, 2006). The review by Sherman and LeResche
(2006) suggests that lack of methodological rigor in the existing studies on menstrual cycle
and pain sensitivity is the basis for the previous inconsistencies reported. In accordance with
the suggestions of recent reviews (Sherman and LeResche, 2006; Greenspan et al., 2007) the
use of hormonal confirmation of menstrual cycle phase, a within-subjects design, a larger
sample size, and three different standardized pain tasks in the current study strongly suggests
that, in fact, the female menstrual cycle does not exert a robust effect on pain sensitivity in
healthy women, nor does it influence gender differences in pain perception.
Our findings are in contrast, however, to a study published after the Sherman and LeResche
(2006) review. Stening et al. (2007) used a within-subjects design and hormonal confirmation
of phase, and did find that the late luteal phase was associated with a shorter time to females’
report of moderate pain relative to the later follicular phase during the hand cold pressor.
However, cycle phase did not influence pain tolerance or a visual analog scale rating of pain.
While the use of a colder ice bath by Stening et al. (2007) relative to the present study (1.5 °C
versus 4.0 °C) may have contributed to their cycle effects, the small sample size (16 females
and 10 males) and lack of detected gender differences in any measure of pain sensitivity limits
the conclusions that can be drawn from the Stening et al. (2007) study.
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It may be important to note that in our study, lack of detecting significant cycle effects is
unlikely due to insufficient power, as the difference in pain sensitivity across the cycle was
minimal (Fig. 1–Fig 3) and we had greater than 90% power to detect moderate effect sizes by
phase had they existed. This is not to say, however, that the menstrual cycle does not influence
sensitivity to other laboratory-based noxious stimuli, since Sherman and LeResche (2006)
concluded in their review that women may be more sensitive to electrical pain stimulation in
the luteal phase. Furthermore, despite the ability of experimental pain sensitivity to predict
clinical pain (Fillingim et al., 1996;Edwards et al., 2001), our results should not be interpreted
to suggest that the menstrual cycle has no effect on clinical pain severity. A recent literature
review on the influence of gonadal hormones on pain suggested that estrogens may modulate
some, but not all types of clinical pain (Craft, 2007), while a separate review in chronic pain
concluded that higher rates of migraine headache, TMD, and back pain occur at the end of the
luteal phase when gonadal hormone levels rapidly decline (Kuba and Quinones-Jenab, 2005).
To our knowledge, this study is the first to examine gender differences in experimental pain
sensitivity as a function of female menstrual cycle phase. Similar results to ours (i.e. lack of
cycle effect on gender differences in pain perception) have been shown in rodents, since it was
found that estrous cycle does not modulate existing sex differences in sensitivity to morphine
antinociception (Mogil et al., 2000). While the reasons for a lack of an effect of menstrual cycle
phase on gender differences in pain sensitivity are not known, one possibility relates to a
putative threshold effect of gonadal hormones on pain sensitivity. For example, even in the
early follicular phase of the menstrual cycle when estrogen and progesterone are at their lowest,
women still exhibit significantly greater hormone levels than men (Kudolo, 2003). While
speculative, it is possible that once a potential threshold level for gonadal hormones is
surpassed, relatively minor fluctuation in gonadal hormone levels as occurs over the normal
female menstrual cycle would be insufficient to influence gender differences in pain sensitivity.
Studies assessing the influence of ovarian suppression with the add-back of exogenous gonadal
hormones in a dose-dependent fashion on gender differences in pain perception might shed
light on this hypothesis, as might studies using pseudopregnancy models.
Another possibility is that mechanisms other than gonadal hormones are contributing to gender
differences in experimental pain sensitivity and may therefore explain why these differences
do not fluctuate with the menstrual cycle. For example, cognitive-affective factors such as pain
coping strategies, familial factors such as social learning and genetics, endogenous pain
mechanisms such as greater analgesic affect of elevated blood pressure in males, and societal
sex role expectancies have been suggested as potential factors contributing to gender
differences in experimental pain perception (Fillingim, 2000).
In conclusion, the results of our study confirm that although women are more sensitive than
men to a variety of noxious stimuli, the menstrual cycle does not exert an influence on pain
sensitivity to cold, heat, or ischemic noxious stimuli in women, nor does it moderate gender
differences in sensitivity to these pain stimuli. These results are limited, however, to healthy
men and women only and may not generalize to women with menstrually related mood
disorders, including premenstrual dysphoric disorder, or to other clinical pain populations.
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Cold pressor pain threshold and tolerance as a function of gender and menstrual cycle phase.
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Heat pain threshold and tolerance as a function of gender and menstrual cycle phase.
Klatzkin et al. Page 11














Ischemic pain threshold and tolerance as a function of gender and menstrual cycle phase.
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Table 1
Mean (±SEM) estradiol and progesterone values by menstrual cycle phase in women.
Early follicular (EF) Late follicular (LF) Luteal (LUT)
Estradiol (pg/ml)a 23.25(0.92) 44.27(3.82) 54.75 (3.26)
Progesterone (pg/ml)b 0.17 (0.02) 0.18 (0.04) 13.77 (1.1)
a
Main effect of menstrual cycle phase, p < .0001: EF < LF < LUT.
b
Main effect of menstrual cycle phase, p < .0001: EF = LF < LUT.
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